Fusion-negative alveolar rhabdomyosarcoma: modification of risk stratification is premature

J Clin Oncol. 2010 Oct 10;28(29):e587-8; author reply e589-90. doi: 10.1200/JCO.2010.30.5466. Epub 2010 Aug 9.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Child
  • Child, Preschool
  • Diagnosis, Differential
  • Disease-Free Survival
  • Humans
  • Oncogene Proteins, Fusion / genetics*
  • Paired Box Transcription Factors / genetics*
  • Rhabdomyosarcoma, Alveolar / diagnosis*
  • Rhabdomyosarcoma, Alveolar / genetics
  • Rhabdomyosarcoma, Alveolar / therapy
  • Rhabdomyosarcoma, Embryonal / diagnosis*
  • Rhabdomyosarcoma, Embryonal / genetics
  • Rhabdomyosarcoma, Embryonal / therapy
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome

Substances

  • Oncogene Proteins, Fusion
  • PAX3-FOXO1A fusion protein, human
  • Paired Box Transcription Factors